Differential sensitivity to methylated DNA by ETS-family transcription factors is intrinsically encoded in their DNA-binding domains

Nucleic Acids Research

Volumn 44, Issue 18, 2016, Pages 8671-8681

  Stephens, Dominique C ^a   Poon, Gregory M K ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CPG METHYLCYTOSINE; CYTARABINE DERIVATIVE; DNA; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG; 5 METHYLCYTOSINE; ONCOPROTEIN; PROTEIN BINDING; PROTO-ONCOGENE PROTEIN SPI-1; TRANSACTIVATOR PROTEIN;

ARTICLE; BINDING AFFINITY; BIOPHYSICS; CONTROLLED STUDY; CPG ISLAND; CRYSTAL STRUCTURE; DNA METHYLATION; GENETIC CONSERVATION; INHIBITION KINETICS; NONHUMAN; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PROTEIN DNA BINDING; SEQUENCE HOMOLOGY; ANIMAL; BINDING SITE; CHEMISTRY; CONFORMATION; GENETICS; METABOLISM; MOUSE; PRINCIPAL COMPONENT ANALYSIS; PROTEIN DOMAIN; THERMODYNAMICS;

5-METHYLCYTOSINE; ANIMALS; BINDING SITES; CPG ISLANDS; DNA; DNA METHYLATION; MICE; NUCLEIC ACID CONFORMATION; PRINCIPAL COMPONENT ANALYSIS; PROTEIN BINDING; PROTEIN DOMAINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; THERMODYNAMICS; TRANS-ACTIVATORS;

EID: 84992316900     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw528     Document Type: Article

References (62)

1. Zhu J, and Emerson S.G. (2002). Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene, 21, 3295-3313.
2. Orkin S.H. (1995). Transcription factors and hematopoietic development. J. Biol. Chem, 270, 4955-4958.
3. Ciau-Uitz A, Wang L, Patient R, and Liu F. (2013). ETS transcription factors in hematopoietic stem cell development. Blood Cells Mol. Dis, 51, 248-255.
4. Scott E.W, Simon M.C, Anastasi J, and Singh H. (1994). Requirement of transcription factor PU1 in the development of multiple hematopoietic lineages. Science, 265, 1573-1577.
5. Hogart A, Lichtenberg J, Ajay S.S, Anderson S, Margulies E.H, and Bodine D.M. (2012). Genome-wide DNA methylation profiles in hematopoietic stem and progenitor cells reveal overrepresentation of ETS transcription factor binding sites. Genome Res, 22, 1407-1418.
6. Pham T.H, Benner C, Lichtinger M, Schwarzfischer L, Hu Y, Andreesen R, Chen W, and Rehli M. (2012). Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states. Blood, 119, e161-e171.
7. de la Rica L, Rodriguez-Ubreva J, Garcia M, Islam A.B, Urquiza J.M, Hernando H, Christensen J, Helin K, Gomez-Vaquero C, and Ballestar E. (2013). PU1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-To-osteoclast differentiation. Genome Biol, 14, R99.
8. Iwafuchi-Doi M, and Zaret K.S. (2014). Pioneer transcription factors in cell reprogramming. Genes Dev, 28, 2679-2692.
9. Tagore M, McAndrew M.J, Gjidoda A, and Floer M. (2015). The Lineage-Specific Transcription Factor PU1 Prevents Polycomb-Mediated Heterochromatin Formation at Macrophage-Specific Genes. Mol. Cell Biol, 35, 2610-2625.
10. DiSpirito J.R, Fang B, Wang F, and Lazar M.A. (2013). Pruning of the Adipocyte Peroxisome Proliferator-Activated Receptor Cistrome by Hematopoietic Master Regulator PU1. Mol. Cell. Biol, 33, 3354-3364.
11. Ghisletti S, Barozzi I, Mietton F, Polletti S, De Santa F, Venturini E, Gregory L, Lonie L, Chew A, Wei C.L, et al. (2010). Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity, 32, 317-328.
12. Heinz S, Benner C, Spann N, Bertolino E, Lin Y.C, Laslo P, Cheng J.X, Murre C, Singh H, and Glass C.K. (2010). Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities. Mol. Cell, 38, 576-589.
13. Barozzi I, Simonatto M, Bonifacio S, Yang L, Rohs R, Ghisletti S, and Natoli G. (2014). Coregulation of Transcription Factor Binding and Nucleosome Occupancy through DNA Features of Mammalian Enhancers. Mol. Cell, 54, 844-857.
14. Sherwood R.I, Hashimoto T, O?Donnell C.W, Lewis S, Barkal A.A, van Hoff J.P, Karun V, Jaakkola T, and Gifford D.K. (2014). Discovery of directional and nondirectional pioneer transcription factors by modeling DNase profile magnitude and shape. Nat. Biotechnol, 32, 171-178.
15. He G, Tolic A, Bashkin J.K, and Poon G.M. (2015). Heterogeneous dynamics in DNA site discrimination by the structurally homologous DNA-binding domains of ETS-family transcription factors. Nucleic Acids Res, 43, 4322-4331.
16. Wang S, Linde M.H, Munde M, Carvalho V.D, Wilson W.D, and Poon G.M. (2014). Mechanistic heterogeneity in site recognition by the structurally homologous DNA-binding domains of the ETS family transcription factors Ets-1 and PU1. J. Biol. Chem, 289, 21605-21616.
17. Stephens D.C, Kim H.M, Kumar A, Farahat A.A, Boykin D.W, and Poon G.M. (2016). Pharmacologic efficacy of PU1 inhibition by heterocyclic dications: a mechanistic analysis. Nucleic Acids Res, 44, 4005-4013.
18. Poon G.M.K. (2012). Sequence discrimination by DNA-binding domain of ETS family transcription factor PU1 is linked to specific hydration of protein-DNA interface. J. Biol. Chem, 287, 18297-18307.
19. Poon G.M.K. (2012). DNA binding regulates the self-Association of the ETS domain of PU1 in a sequence-dependent manner. Biochemistry, 51, 4096-4107.
20. Tataurov A.V, You Y, and Owczarzy R. (2008). Predicting ultraviolet spectrum of single stranded and double stranded deoxyribonucleic acids. Biophys. Chem, 133, 66-70.
21. Lu X.J, and Olson W.K. (2003). 3DNA: a software package for the analysis, rebuilding and visualization of three-dimensional nucleic acid structures. Nucleic Acids Res, 31, 5108-5121.
22. Wang P, Brank A.S, Banavali N.K, Nicklaus M.C, Marquez V.E, Christman J.K, and MacKerell A.D. (2000). Use of oligodeoxyribonucleotides with conformationally constrained abasic sugar targets to probe the mechanism of base flipping by HhaI DNA (cytosine C5)-methyltransferase. J. Am. Chem. Soc, 122, 12422-12434.
23. Lavery R, Moakher M, Maddocks J.H, Petkeviciute D, and Zakrzewska K. (2009). Conformational analysis of nucleic acids revisited: Curves+. Nucleic Acids Res, 37, 5917-5929.
24. Poon G.M, and Macgregor R.B. Jr (2003) Base coupling in sequence-specific site recognition by the ETS domain of murine PU1. J. Mol. Biol, 328, 805-819.
25. Nye J.A, Petersen J.M, Gunther C.V, Jonsen M.D, and Graves B.J. (1992). Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif. Genes Dev, 6, 975-990.
26. Graves B.J, Gillespie M.E, and McIntosh L.P. (1996). DNA binding by the ETS domain. Nature, 384, 322.
27. Wei G.H, Badis G, Berger M.F, Kivioja T, Palin K, Enge M, Bonke M, Jolma A, Varjosalo M, Gehrke A.R, et al. (2010). Genome-wide analysis of ETS-family DNA-binding invitro and in vivo. EMBO J, 29, 2147-2160.
28. Petersen J.M, Skalicky J.J, Donaldson L.W, McIntosh L.P, Alber T, and Graves B.J. (1995). Modulation of transcription factor Ets-1 DNA binding: DNA-induced unfolding of an alpha helix. Science, 269, 1866-1869.
29. Wang H, McIntosh L.P, and Graves B.J. (2002). Inhibitory module of Ets-1 allosterically regulates DNA binding through a dipole-facilitated phosphate contact. J. Biol. Chem, 277, 2225-2233.
30. Jonsen M.D, Petersen J.M, Xu Q.P, and Graves B.J. (1996). Characterization of the cooperative function of inhibitory sequences in Ets-1. Mol. Cell. Biol, 16, 2065-2073.
31. Kodandapani R, Pio F, Ni C.Z, Piccialli G, Klemsz M, McKercher S, Maki R.A, and Ely K.R. (1996). A new pattern for helix-Turn-helix recognition revealed by the PU1 ETS-domain-DNA complex. Nature, 380, 456-460.
32. Garvie C.W, Hagman J, and Wolberger C. (2001). Structural studies of Ets-1/Pax5 complex formation on DNA. Mol. Cell, 8, 1267-1276.
33. Strauss-Soukup J.K, and Maher L.J. 3rd (1997) Role of asymmetric phosphate neutralization in DNA bending by PU1. J. Biol. Chem, 272, 31570-31575.
34. Okonogi T.M, Alley S.C, Harwood E.A, Hopkins P.B, and Robinson B.H. (2002). Phosphate backbone neutralization increases duplex DNA flexibility: a model for protein binding. Proc. Natl. Acad. Sci. U.S.A, 99, 4156-4160.
35. Szymczyna B.R, and Arrowsmith C.H. (2000). DNA binding specificity studies of four ETS proteins support an indirect read-out mechanism of protein-DNA recognition. J. Biol. Chem, 275, 28363-28370.
36. Yokomori N, Kobayashi R, Moore R, Sueyoshi T, and Negishi M. (1995). A DNA methylation site in the male-specific P450 (Cyp 2d-9) promoter and binding of the heteromeric transcription factor GABP. Mol. Cell. Biol, 15, 5355-5362.
37. Umezawa A, Yamamoto H, Rhodes K, Klemsz M.J, Maki R.A, and Oshima R.G. (1997). Methylation of an ETS site in the intron enhancer of the keratin 18 gene participates in tissue-specific repression. Mol. Cell. Biol, 17, 4885-4894.
38. Lucas M.E, Crider K.S, Powell D.R, Kapoor-Vazirani P, and Vertino P.M. (2009). Methylation-sensitive Regulation of TMS1/ASC by the Ets Factor, GA-binding Protein. J. Biol. Chem, 284, 14698-14709.
39. Nickel J, Short M.L, Schmitz A, Eggert M, and Renkawitz R. (1995). Methylation of the mouse M-lysozyme downstream enhancer inhibits heterotetrameric GABP binding. Nucleic Acids Res, 23, 4785-4792.
40. Polansky J.K, Schreiber L, Thelemann C, Ludwig L, Kruger M, Baumgrass R, Cording S, Floess S, Hamann A, and Huehn J. (2010). Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells. J. Mol. Med. (Berl.), 88, 1029-1040.
41. Cooper C.D, Newman J.A, Aitkenhead H, Allerston C.K, and Gileadi O. (2015). Structures of the Ets protein DNA-binding domains of transcription factors Etv1, Etv4, Etv5, and Fev: determinants of DNA binding and redox regulation by disulfide bond formation. J. Biol. Chem, 290, 13692-13709.
42. Toyota M, Shen L, Ohe-Toyota M, Hamilton S.R, Sinicrope F.A, and Issa J.-P.J. (2000). Aberrant methylation of the cyclooxygenase 2 CpG island in colorectal tumors. Cancer Res, 60, 4044-4048.
43. Asting A.G, Caren H, Andersson M, Lonnroth C, Lagerstedt K, and Lundholm K. (2011). COX-2 gene expression in colon cancer tissue related to regulating factors and promoter methylation status. BMC Cancer, 11, 238.
44. Hollenhorst P.C, McIntosh L.P, and Graves B.J. (2011). Genomic and biochemical insights into the specificity of ETS transcription factors. Annu. Rev. Biochem, 80, 437-471.
45. Wang J, Zhuang J, Iyer S, Lin X, Whitfield T.W, Greven M.C, Pierce B.G, Dong X, Kundaje A, Cheng Y, et al. (2012). Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res, 22, 1798-1812.
46. Gaston K, and Fried M. (1995). CpG methylation has differential effects on the binding of YY1 and ETS proteins to the bi-directional promoter of the Surf-1 and Surf-2 genes. Nucleic Acids Res, 23, 901-909.
47. Goetz T.L, Gu T.L, Speck N.A, and Graves B.J. (2000). Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor alpha2. Mol. Cell. Biol, 20, 81-90.
48. Pham T.H, Minderjahn J, Schmidl C, Hoffmeister H, Schmidhofer S, Chen W, Langst G, Benner C, and Rehli M. (2013). Mechanisms of in vivo binding site selection of the hematopoietic master transcription factor PU1. Nucleic Acids Res, 41, 6391-6402.
49. Wilkinson N.C, and Navarro J. (1999). PU1 regulates the CXCR1 promoter. J. Biol. Chem, 274, 438-443.
50. Smith M.F. Jr, Carl V.S, Lodie T, and Fenton M.J. (1998). Secretory interleukin-1 receptor antagonist gene expression requires both a PU1 and a novel composite NF-kappaB/PU1/.GA-binding protein binding site. J. Biol. Chem, 273, 24272-24279.
51. Honda H, Ozawa K, Yazaki Y, and Hirai H. (1997). Identification of PU1 and Sp1 as essential transcriptional factors for the promoter activity of mouse tec gene. Biochem. Biophys. Res. Commun, 234, 376-381.
52. Foxler D.E, James V, Shelton S.J, Vallim T.Q, Shaw P.E, and Sharp T.V. (2011). PU1 is a major transcriptional activator of the tumour suppressor gene LIMD1. FEBS Lett, 585, 1089-1096.
53. Joo M, Kwon M, Cho Y.J, Hu N, Pedchenko T.V, Sadikot R.T, Blackwell T.S, and Christman J.W. (2009). Lipopolysaccharide-dependent interaction between PU1 and c-Jun determines production of lipocalin-Type prostaglandin D synthase and prostaglandin D2 in macrophages. Am. J. Physiol. Lung Cell Mol. Physiol, 296, L771-L779.
54. Zhang J.A, Mortazavi A, Williams B.A, Wold B.J, and Rothenberg E.V. (2012). Dynamic transformations of genome-wide epigenetic marking and transcriptional control establish T cell identity. Cell, 149, 467-482.
55. van Riel B, and Rosenbauer F. (2014). Epigenetic control of hematopoiesis: the PU1 chromatin connection. Biol. Chem, 395, 1265-1274.
56. Packer M.J, and Hunter C.A. (1998). Sequence-dependent DNA structure: the role of the sugar-phosphate backbone. J. Mol. Biol, 280, 407-420.
57. Bharanidharan D, and Gautham N. (2006). Principal component analysis of DNA oligonucleotide structural data. Biochem. Biophys. Res. Commun, 340, 1229-1237.
58. Carvalho A.T.P, Gouveia L, Kanna C.R, Wärmländer S.K.T.S, Platts J.A, and Kamerlin S.C.L. (2014). Understanding the structural and dynamic consequences of DNA epigenetic modifications: Computational insights into cytosine methylation and hydroxymethylation. Epigenetics, 9, 1604-1612.
59. Pérez A, Castellazzi C.L, Battistini F, Collinet K, Flores O, Deniz O, Ruiz M.L, Torrents D, Eritja R, Soler-López M, et al. (2012). Impact of methylation on the physical properties of DNA. Biophys. J, 102, 2140-2148.
60. Lazarovici A, Zhou T, Shafer A, Dantas Machado A.C, Riley T.R, Sandstrom R, Sabo P.J, Lu Y, Rohs R, Stamatoyannopoulos J.A, et al. (2013). Probing DNA shape and methylation state on a genomic scale with DNase I. Proc. Natl. Acad. Sci. U.S.A, 110, 6376-6381.
61. Jones P.A, and Liang G. (2009). Rethinking how DNA methylation patterns are maintained. Nat. Rev. Genet, 10, 805-811.
62. Jones P.A, and Taylor S.M. (1980). Cellular differentiation, cytidine analogs and DNA methylation. Cell, 20, 85-93.